Hyunjae Ryan Kim

Dr. Hyunjae Ryan Kim is currently the leader of a team at Gilead Sciences, which specializes in oncology genomics analytics. He is responsible for developing multimodal AI algorithms and applications used in clinical development for oncology. Additionally, he researches how to improve cancer treatment using deep learning and multi-omics data integration by modulating tumor microenvironments.


Dr. Kim previously held the associate director of pediatric oncology bioinformatics position at the Texas Children’s Cancer Center at Baylor College of Medicine (BCM). Before joining BCM, he was a senior computational biologist at the Memorial Sloan Kettering Cancer Center. Dr. Kim and his team developed routine genomic profiling systems (MSK-IMPACT) and matching treatment options for all patients in MSKCC. He also served as research faculty at the Rockefeller University, where he built systems to decipher epigenetic codes and transcriptional controls from multi-omics data with C. David Allis and Thomas Tuschl. Dr. Kim completed his postdoctoral training in Systems Biology at Columbia University Medical Center.